This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Stefanie Lindemann: Innovator in On-Demand Contraception
Introduction
Stefanie Lindemann is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the area of contraception. Her innovative approach focuses on providing women with more control over their reproductive health.
Latest Patents
Stefanie holds a patent for her invention titled "Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception." This invention relates to a method of hormonal female-controlled 'on demand' contraception. It involves a pharmaceutical preparation that combines a COX inhibitor and levonorgestrel, which is taken prior to expected sexual intercourse. The patent addresses the need for effective and accessible contraceptive options for women.
Career Highlights
Stefanie is currently employed at Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. Her work at Bayer has allowed her to collaborate with other experts in the field and contribute to groundbreaking research and development in women's health.
Collaborations
Stefanie has worked alongside notable colleagues such as Peter Serno and Bernhard Lindenthal. Their combined expertise has fostered an environment of innovation and progress in the pharmaceutical industry.
Conclusion
Stefanie Lindemann's contributions to on-demand contraception represent a significant advancement in women's reproductive health. Her innovative patent and work at Bayer Pharma highlight her commitment to improving contraceptive options for women worldwide.